CAS 51352-88-6

Methyl 3-[2-[methyl(phenylmethyl)amino]ethyl]benzoate

Description:

Methyl 3-[2-[methyl(phenylmethyl)amino]ethyl]benzoate, with the CAS number 51352-88-6, is an organic compound characterized by its ester functional group and a complex amine structure. It features a methyl ester derived from benzoic acid, which contributes to its aromatic properties. The presence of a secondary amine, specifically a methyl(phenylmethyl)amino group, indicates potential for hydrogen bonding and influences its solubility and reactivity. This compound is likely to exhibit moderate polarity due to the combination of hydrophobic aromatic rings and hydrophilic ester and amine functionalities. Its molecular structure suggests potential applications in pharmaceuticals or as an intermediate in organic synthesis, where the amine group may participate in further chemical reactions. Additionally, the compound's characteristics, such as melting point, boiling point, and solubility, would depend on its molecular interactions and the surrounding environment. Safety and handling precautions should be observed, as with any chemical substance, due to potential toxicity or reactivity.

Formula: C₁₈H₂₁NO₂

InChI: InChI=1S/C18H21NO2/c1-19(14-16-7-4-3-5-8-16)12-11-15-9-6-10-17(13-15)18(20)21-2/h3-10,13H,11-12,14H2,1-2H3

InChI key: InChIKey=IGJQEMHBYKNIQR-UHFFFAOYSA-N

SMILES: C(OC)(=O)C1=CC(CCN(CC2=CC=CC=C2)C)=CC=C1

Synonyms:

• Benzoic acid, 3-[2-[methyl(phenylmethyl)amino]ethyl]-, methyl ester
• Methyl 3-[2-[methyl(phenylmethyl)amino]ethyl]benzoate
• m-[2-(Benzylmethylamino)ethyl]benzoic acid methyl ester
• Methyl m-[2-(benzylmethylamino)ethyl]benzoate
• Methyl 3-[2-(benzylmethylamino)ethyl]benzoate

PRL-8-53

CAS: 51352-88-6

PRL-8-53 is an inhibitor that has shown promise in the treatment of tumors and cancer. It is a Chinese medicinal analog that has been isolated from urine, and it exhibits potent inhibitory activity against human kinases. PRL-8-53 has been shown to induce apoptosis in cancer cells, making it a promising anticancer agent. In addition to its potential use as a cancer treatment, PRL-8-53 may also have applications in the treatment of other diseases and conditions that are characterized by abnormal protein kinase activity. With its potent inhibitory effects on protein kinases, PRL-8-53 represents a promising avenue for future research into novel therapies for cancer and other diseases.

Formula: C₁₈H₂₁NO₂

Purity: Min. 95%

Molecular weight: 283.4 g/mol

Ref: 3D-BCA35288